Advertisement

 

 

Volume expansion of periaqueductal gray in episodic migraine: a pilot MRI structural imaging study.

Volume expansion of periaqueductal gray in episodic migraine: a pilot MRI structural imaging study.
Author Information (click to view)

Chen Z, Chen X, Liu M, Liu S, Ma L, Yu S,


Chen Z, Chen X, Liu M, Liu S, Ma L, Yu S, (click to view)

Chen Z, Chen X, Liu M, Liu S, Ma L, Yu S,

Advertisement
Share on FacebookTweet about this on TwitterShare on LinkedIn

The journal of headache and pain 2017 08 1518(1) 83 doi 10.1186/s10194-017-0797-z
Abstract
BACKGROUND
The periaqueductal gray (PAG) dysfunction was recognized in migraine, and the nonspecific PAG lesions were also observed in episodic migraine (EM) recently. However, the PAG volume change was not totally detected in EM up to now. Herein, the aim of this study was to investigate altered PAG volume in EM patients based on high resolution brain structural image.

METHODS
The brain structural images were obtained from 18 normal controls (NC), 18 EM patients and 16 chronic migraine (CM) on 3.0 T MR system. PAG template was created based on the ICBM152 gray matter template using MRIcron, and the individual PAG was created by applying the deformation field to the PAG template after structural image segment. One-way analysis of covariance, partial correlation analysis and Receiver operating characteristics (ROC) curve were applied.

RESULTS
EM had a larger PAG volume (0.35 ± 0.02 ml) than that (0.32 ± 0.02 ml) of NC (P = 0.017). The PAG volume of CM (0.33 ± 0.02 ml) was negatively related to the VAS score (P = 0.03). ROC analysis demonstrated that PAG volume has higher diagnostic efficacy (AUC, 0.731; Sensitivity, 0.556; Specificity, 0.889) for NC vs. EM compared with that NC vs. CM (AUC, 0.634; Sensitivity, 0.438; Specificity, 0.833) and EM vs. CM (AUC, 0.618; Sensitivity, 0.813; Specificity, 0.556).

CONCLUSION
PAG volume expansion may be the direct impairment evidence on the brain in EM, and could be considered as a diagnostic and evaluated imaging biomarker in migraine.

Submit a Comment

Your email address will not be published. Required fields are marked *

eleven + 4 =

[ HIDE/SHOW ]